Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Vaccines

  Free Subscription


Articles published in Infect Immun

Retrieve available abstracts of 80 articles:
HTML format
Text format



Single Articles


    March 2010
  1. TAXT A , Aasland R, Sommerfelt H, Nataro J, et al
    Heat-Stable Enterotoxin of Enterotoxigenic Escherichia coli as Vaccine Target.
    Infect Immun. 2010.
    PubMed     Text format     Related articles    Abstract available


  2. ZHANG Y , Bliska JB
    YopJ-promoted cytotoxicity and systemic colonization is associated with higher levels of murine IL-18, IFN{gamma} and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection.
    Infect Immun. 2010.
    PubMed     Text format     Related articles    Abstract available


  3. MAUDUIT M , Tewari R, Depinay N, Kayibanda M, et al
    A minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites.
    Infect Immun. 2010.
    PubMed     Text format     Related articles    Abstract available


  4. TRANT CG , Lacerda TL, Carvalho NB, Azevedo V, et al
    Brucella abortus phosphoglycerate kinase (pgk) mutant is highly attenuated and induces superior protection than vaccine strain 19 in immune compromised and immune competent mice.
    Infect Immun. 2010.
    PubMed     Text format     Related articles    Abstract available


    February 2010
  5. SUKUMAR N , Sloan GP, Conover MS, Love CF, et al
    Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in the acellular pertussis vaccines.
    Infect Immun. 2010.
    PubMed     Text format     Related articles    Abstract available


  6. NOAH CE , Malik M, Bublitz DC, Camenares D, et al
    GroEL and Lipopolysaccharide from Francisella tularensis Live Vaccine Strain Synergistically Activate Human Macrophages.
    Infect Immun. 2010.
    PubMed     Text format     Related articles    Abstract available


    January 2010
  7. SUN W , Roland KL, Kuang X, Branger CG, et al
    Yersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.
    Infect Immun. 2010.
    PubMed     Text format     Related articles    Abstract available


  8. SUTTEN EL , Norimine J, Beare PA, Heinzen RA, et al
    Anaplasma marginale type IV secretion system proteins VirB2, VirB7, VirB11 and VirD4 are immunogenic components of a protective bacterial membrane vaccine.
    Infect Immun. 2010.
    PubMed     Text format     Related articles    Abstract available


  9. OKAN NA , Mena P, Benach JL, Bliska JB, et al
    smpB-ssrA Mutant of Yersinia pestis Functions As a Live Attenuated Vaccine to Protect Mice Against Pulmonary Plague Infection.
    Infect Immun. 2010.
    PubMed     Text format     Related articles    Abstract available


  10. GIDDINGS OK , Eickhoff CS, Sullivan NL, Hoft DF, et al
    Intranasal vaccinations with the trans-sialidase antigen plus CpG adjuvant induce mucosal immunity protective against conjunctival T. cruzi challenges.
    Infect Immun. 2010.
    PubMed     Text format     Related articles    Abstract available


    December 2009
  11. SCANDURRA GM , de Lisle GW, Cavaignac SM, Young M, et al
    Assessment of Live Candidate Vaccines for Paratuberculosis in Animal Models and Macrophages.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  12. PENARETE VARGAS DM , Mevelec MN, Dion S, Seche E, et al
    Protection against lethal Neospora caninum infection in mice induced by heterologous vaccination with a mic1-3 knockout Toxoplasma gondii strain.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  13. CAMPODONICO VL , Llosa NJ, Grout M, Doring G, et al
    Evaluation of Flagella versus Flagellin of Pseudomonas aeruginosa as Vaccines.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


    November 2009
  14. GENING M , Maira-Litran T, Kropec A, Skurnik D, et al
    Synthetic {beta}-(1->6)-linked N-acetylated and non-acetylated oligoglucosamines to produce conjugate vaccines for bacterial pathogens.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  15. YOSHIDA S , Araki H, Yokomine T
    Baculovirus-based nasal drop vaccine confers complete protection against malaria by natural boosting of vaccine-induced antibodies in mice.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  16. DEMANGA CG , Daher LJ, Prieur E, Blanc C, et al
    Towards the Rational Design of a Malaria Vaccine Construct; Example of the MSP3 Family, Part II: Antigenicity Studies.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  17. PETERS SE , Paterson GK, Bandularatne ES, Northen HC, et al
    Salmonella enterica serovar Typhimurium trxA mutants are protective against virulent challenge and induce less inflammation than the live-attenuated vaccine strain SL3261.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


    October 2009
  18. KONG Q , Liu Q, Roland KL, Curtiss R 3rd, et al
    Regulated Delayed Expression of rfaH in an Attenuated Salmonella Vaccine Enhances Immunogenicity of Outer Membrane Proteins and a Heterologous Antigen.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  19. OSCHERWITZ J , Yu F, Cease KB
    A heterologous helper T cell epitope enhances the immunogenicity of a multiple antigenic peptide vaccine targeting the cryptic loop neutralizing determinant of Bacillus anthracis.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  20. CARRERO JA , Calderon B, Vivanco-Cid H, Unanue ER, et al
    Recombinant Listeria monocytogenes expressing a cell wall-associated listeriolysin O is weakly virulent but immunogenic.
    Infect Immun. 2009;77:4371-82.
    PubMed     Text format     Related articles    Abstract available


  21. SZABA FM , Kummer LW, Wilhelm LB, Lin JS, et al
    D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague.
    Infect Immun. 2009;77:4295-304.
    PubMed     Text format     Related articles    Abstract available


    September 2009
  22. OLUGBILE S , Kulangara C, Bang G, Bertholet S, et al
    Vaccine potentials of an intrinsically unstructured fragment derived from the blood stage associated P. falciparum protein PFF0165c.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  23. RAMAN VS , O'Donnell J, Bailor HR, Goto W, et al
    ML0276 vaccination reduces local inflammation, but not bacterial burden, during experimental M. leprae infection.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  24. GIGLEY JP , Fox BA, Bzik DJ
    Long-term immunity to lethal acute or chronic Type II Toxoplasmosis gondii infection is effectively induced in genetically susceptible C57BL/6 mice by immunization with an attenuated Type I vaccine strain.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  25. BERCHTOLD C , Panthel K, Jellbauer S, Kohn B, et al
    Superior Protective Immunity against Murine Listeriosis by Combined Vaccination with CpG DNA and Recombinant Salmonella.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  26. ARAKAWA T , Tachibana M, Miyata T, Harakuni T, et al
    Malaria ookinete surface protein-based vaccination via the intranasal route completely blocks parasite transmission both in passive and active vaccination regimes in a rodent malaria infection model.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  27. GLENN GM , Francis DH, Danielsen EM
    Toxin-Mediated Effects on the Innate Mucosal Defenses: Implications for Enteric Vaccines.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  28. WILLIAMS JN , Skipp PJ, O'Connor CD, Christodoulides M, et al
    Immunoproteomic analysis of the development of natural immunity in subjects colonised by Neisseria meningitidis reveals potential vaccine candidates.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  29. GROVER A , Taylor J, Troudt J, Keyser A, et al
    Kinetics of the immune response profile in guinea pigs after vaccination with BCG and infection with Mycobacterium tuberculosis.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  30. MEONI E , Faenzi E, Frigimelica E, Zedda L, et al
    CT043, a protective antigen that induces a CD4+ Th1 response during Chlamydia trachomatis infection in mice and humans.
    Infect Immun. 2009;77:4168-76.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  31. BUENDIA AJ , Ortega N, Caro MR, Del Rio L, et al
    B cells are essential for moderating the inflammatory response and controlling bacterial multiplicaction in a mouse model of vaccination against Chlamydophila abortus infection.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  32. XIN W , Li Y, Mo H, Roland KL, et al
    PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extends and enhances protection against Streptococcus pneumoniae.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  33. SCHURWANZ N , Jacobs E, Dumke R
    A strategy to create chimeric proteins derived from functional adhesin regions of Mycoplasma pneumoniae for vaccine development.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  34. BARBOSA A , Naniche D, Aponte JJ, Manaca MN, et al
    P. falciparum specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  35. DE ALENCAR BC , Persechini PM, Haolla FA, de Oliveira G, et al
    Perforin and Interferon-{gamma} expression are required for CD4+ and CD8+ T cell-dependent protective immunity against a human parasite (Trypanosoma cruzi) elicited by a heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  36. LI B , Zhou L, Guo J, Wang X, et al
    High-throughput identification of new protective antigens from Yersinia pestis live vaccine by ELISPOT.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  37. DRISKELL LO , Yu XJ, Zhang L, Liu Y, et al
    Directed mutagenesis of the Rickettsia prowazekii pld gene encoding phospholipase D.
    Infect Immun. 2009;77:3244-8.
    PubMed     Text format     Related articles    Abstract available


    July 2009
  38. SHARMA J , Li Q, Mishra BB, Georges MJ, et al
    Vaccination with an attenuated strain of Francisella novicida prevents T cell depletion and protects mice infected with the wildtype strain from severe sepsis.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  39. CAO S , Guo A, Liu Z, Tan Y, et al
    Investigation of New Dominant Negative Inhibitors of Anthrax Protective Antigen Mutants for use in Therapy and Vaccination.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  40. BURALL LS , Rodolakis A, Rekiki A, Myers GS, et al
    Genomic analysis of attenuated (live vaccine) Chlamydia abortus reveals defects in central metabolism and surface proteins.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  41. DAHER LJ , Demanga CG, Prieur E, Perignon JL, et al
    Towards the rational design of a malaria vaccine construct: example of the MSP3 family. Part I: Immunogenicity studies in models.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  42. TU YC , Lu MC, Chiang MK, Huang SP, et al
    Genetic requirements for Klebsiella pneumoniae-induced liver abscess in an oral infection model.
    Infect Immun. 2009;77:2657-71.
    PubMed     Text format     Related articles    Abstract available


  43. CHIONH YT , Wee JL, Every AL, Ng GZ, et al
    M-cell targeting of whole killed bacteria induces protective immunity against gastrointestinal pathogens.
    Infect Immun. 2009;77:2962-70.
    PubMed     Text format     Related articles    Abstract available


    June 2009
  44. GUO X , Barroso L, Becker SM, Lyerly DM, et al
    Protection against Intestinal Amebiasis by a Recombinant Vaccine is Transferable by T cells and Mediated by IFN-{gamma}
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  45. LEONG ML , Hampl J, Liu W, Mathur S, et al
    Impact of pre-existing vector-specific immunity on vaccine potency: characterization of Listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies in mice using recombinant vaccines.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  46. JORDAN KA , Wilson EH, Tait ED, Fox BA, et al
    Kinetics and phenotype of vaccine-induced CD8+ T cell responses to Toxoplasma gondii.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  47. SALOMONSSON E , Kuoppa K, Forslund AL, Zingmark C, et al
    Reintroduction of two deleted virulence loci restores full virulence to the live vaccine strain (LVS) of Francisella tularensis.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  48. XUE J , Chen X, Selby D, Hung CY, et al
    A Genetically-Engineered Live Attenuated Vaccine of Coccidioides Protects BALB/c Mice Against Coccidioidomycosis.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  49. VORDERMEIER HM , Villarreal-Ramos B, Cockle PJ, Macaulay M, et al
    Viral booster vaccines improve BCG-induced protection Against bovine Tuberculosis.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  50. OSCHERWITZ J , Yu F, Jacobs JL, Liu TH, et al
    A synthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


    May 2009
  51. NYGREN E , Li BL, Holmgren J, Attridge SR, et al
    Establishment of an adult mouse model for direct evaluation of the efficacy of vaccines against Vibrio cholerae.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  52. SARDA V , Kaslow DC, Williamson KC
    Approaches to Malaria Vaccine Development using the Retrospectroscope.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  53. GIANFALDONI C , Maccari S, Pancotto L, Rossi G, et al
    Sortase A confers protection against Streptococcus pneumoniae in mice.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  54. LU YJ , Forte S, Thompson CM, Anderson PW, et al
    Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.
    Infect Immun. 2009;77:2076-83.
    PubMed     Text format     Related articles    Abstract available


  55. COLLAZO CM , Meierovics AI, De Pascalis R, Wu TH, et al
    T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria.
    Infect Immun. 2009;77:2010-21.
    PubMed     Text format     Related articles    Abstract available


  56. MATIC JN , Terry TD, Van Bockel D, Maddocks T, et al
    Development of non-antibiotic-resistant, chromosomally based, constitutive and inducible expression systems for aroA-attenuated Salmonella enterica Serovar Typhimurium.
    Infect Immun. 2009;77:1817-26.
    PubMed     Text format     Related articles    Abstract available


  57. MOENS L , Jeurissen A, Nierkens S, Boon L, et al
    Generation of antibody responses to pneumococcal capsular polysaccharides is independent of CD1 expression in mice.
    Infect Immun. 2009;77:1976-80.
    PubMed     Text format     Related articles    Abstract available


    April 2009
  58. SHONE C , Agostini H, Clancy J, Gu M, et al
    A Bivalent Recombinant Vaccine for Botulinum Types A and B Neurotoxins Based on a Polypeptide Comprising Their Effector and Translocation Domains that is Protective against the Predominant A and B subtypes.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  59. TERTILT C , Joh J, Krause A, Chou P, et al
    Expression of B Cell Activating Factor Enhances Protective Immunity of a Vaccine Against P. aeruginosa.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  60. GLOWALLA E , Tosetti B, Kronke M, Krut O, et al
    Proteomics-Based Identification of Anchorless Cell Wall Proteins as Vaccine Candidates against Staphylococcus aureus.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  61. WEIMER ET , Lu H, Kock ND, Wozniak DJ, et al
    A vaccine containing OprF311-341-OprI-type A- and B-flagellin fusion proteins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  62. BUCHAN BW , McCaffrey RL, Lindemann SR, Allen LA, et al
    Identification of migR, a regulatory element of the Francisella tularensis Live Vaccine Strain iglABCD virulence operon required for normal replication and trafficking in macrophages.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  63. OSORIO M , Wu Y, Singh S, Merkel TJ, et al
    Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.
    Infect Immun. 2009;77:1475-82.
    PubMed     Text format     Related articles    Abstract available


    March 2009
  64. GARCIA PELAYO MC , Uplekar S, Keniry A, Mendoza Lopez P, et al
    Comprehensive survey of single nucleotide polymorphisms across Mycobacterium bovis and BCG vaccine strains refines the genealogy and defines a minimal set of SNPs that separate virulent M. bovis and BCG.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  65. CURTISS R 3RD , Wanda SY, Gunn BM, Zhang X, et al
    Salmonella enterica serovar typhimurium strains with regulated delayed attenuation in vivo.
    Infect Immun. 2009;77:1071-82.
    PubMed     Text format     Related articles    Abstract available


    February 2009
  66. SILVA-FLANNERY LM , Cabrera-Mora M, Dickherber M, Moreno A, et al
    Polymeric linear peptide chimeric vaccine-induced anti-malaria immunity is associated with enhanced in vitro antigen loading.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  67. REASON D , Liberato J, Sun J, Keitel W, et al
    Frequency and domain specificity of toxin-neutralizing paratopes in the human antibody response to the anthrax vaccine AVA.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  68. YOSHIDA S , Kawasaki M, Hariguchi N, Hirota K, et al
    Baculovirus Dual Expression System in vaccine development: A baculovirus-based vaccine induces strong protection against Plasmodium berghei sporozoite challenge.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  69. BRAGA CJ , Rittner GM, Munoz Henao JE, Teixeira AF, et al
    Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  70. THOMAS RJ , Webber D, Collinge A, Stagg AJ, et al
    Small and large particle inhalational plague shows different pathology but equal responsiveness to the rF1+rV vaccine or ciprofloxacin in the murine model of disease.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  71. SUKUMAR N , Love CF, Conover MS, Kock ND, et al
    Active and passive immunizations with Bordetella colonization factor A protect mice against respiratory challenge with Bordetella bronchiseptica.
    Infect Immun. 2009;77:885-95.
    PubMed     Text format     Related articles    Abstract available


  72. ARENAS-GAMBOA AM , Ficht TA, Kahl-McDonagh MM, Gomez G, et al
    The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle.
    Infect Immun. 2009;77:877-84.
    PubMed     Text format     Related articles    Abstract available


    January 2009
  73. BHOWMICK S , Mazumdar T, Ali N
    Vaccination Route That Induces TGF-{beta} Production Fails to Elicit Protective Immunity Against Leishmania donovani Infection.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  74. SKOBLE J , Beaber JW, Gao Y, Lovchik JA, et al
    Killed But Metabolically Active Bacillus anthracis Vaccines Induce Broad and Protective Immunity Against Anthrax.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  75. BOGAERT D , Weinberger D, Thompson C, Lipsitch M, et al
    Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model.
    Infect Immun. 2009.
    PubMed     Text format     Related articles    Abstract available


  76. NGUYEN ML , Crowe SR, Kurella S, Teryzan S, et al
    Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.
    Infect Immun. 2009;77:162-9.
    PubMed     Text format     Related articles    Abstract available


  77. QIN A , Scott DW, Thompson JA, Mann BJ, et al
    Identification of an essential Francisella tularensis subsp. tularensis virulence factor.
    Infect Immun. 2009;77:152-61.
    PubMed     Text format     Related articles    Abstract available


  78. PASQUEVICH KA , Estein SM, Samartino CG, Zwerdling A, et al
    Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Infect Immun. 2009;77:436-45.
    PubMed     Text format     Related articles    Abstract available


    December 2008
  79. TCHILIAN EZ , Desel C, Forbes EK, Bandermann S, et al
    Immunogenicity and protective efficacy against murine tuberculosis of prime-boost regimes with {Delta}ureC hly+ rBCG and MVA85A.
    Infect Immun. 2008.
    PubMed     Text format     Related articles    Abstract available


    November 2008
  80. GUPTA A , Mol N, Mani J, Upadhyay P, et al
    Immunogenicity and protective efficacy of M.w against M.tuberculosis in mice immunized with live M.w by aerosol or parenteral route and compared with killed M.w.
    Infect Immun. 2008.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: